Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma

Clinical trial NCT02202200 · UNKNOWN

Trial details

NCT number

NCT02202200

Sponsor

Assistance Publique - Hôpitaux de Paris

Status

UNKNOWN

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2014-05-01

Primary completion

2016-11-01

Enrollment

40

View on ClinicalTrials.gov